Drug Profile
Budesonide dry-powder inhalation - Vectura
Alternative Names: Budesonide ClickhalerLatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Innovata
- Developer Innovata; Viatris Inc
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Antivirals; Glucocorticoids; Pregnenediones; Small molecules
- Mechanism of Action Immunosuppressants; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
- Available For Licensing Yes
Highest Development Phases
- Marketed Asthma